Loading...
Proepithelin is an autocrine growth factor for bladder cancer
Lovat, Francesca Bitto, Alessandro Xu, Shi-Qiong Fassan, Matteo Goldoni, Silvia Metalli, David Wubah, Vera McCue, Peter Serrero, Ginette Gomella, Leonard G.
Lovat, Francesca
Bitto, Alessandro
Xu, Shi-Qiong
Fassan, Matteo
Goldoni, Silvia
Metalli, David
Wubah, Vera
McCue, Peter
Serrero, Ginette
Gomella, Leonard G.
Citations
Altmetric:
Genre
Journal article
Date
2009-02-23
Advisor
Committee member
Group
Department
Biology
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
https://doi.org/10.1093/carcin/bgp050
Abstract
The growth factor proepithelin functions as an important regulator of proliferation and motility. Proepithelin is overexpressed in a great variety of cancer cell lines and clinical specimens of breast, ovarian and renal cancer, as well as glioblastomas. Using recombinant proepithelin on 5637 transitional cell carcinoma-derived cells, we have shown previously that proepithelin plays a critical role in bladder cancer by promoting motility of bladder cancer cells. In this study, we used the ONCOMINE database and gene microarray analysis tool to analyze proepithelin expression in several bladder cancer microarray studies. We found a statistically significant increase in proepithelin messenger RNA expression in bladder cancers vis-Ã -vis non-neoplastic tissues, and this was associated with pathologic and prognostic parameters. Targeted downregulation of proepithelin in T24 transitional carcinoma cells with small hairpin RNA inhibited both Akt and mitogen-activated protein kinase pathways, severely reduced the ability of T24 cells to proliferate in the absence of serum and inhibited migration, invasion and wound healing. In support of these in vitro results, we discovered that proepithelin expression was significantly upregulated in invasive bladder cancer tissues compared with normal urothelium. In addition, proepithelin was secreted in the urine, where it was detectable by immunoblotting and enzyme-linked immunosorbent assay. Collectively, these results support the hypothesis that proepithelin may play a critical role as an autocrine growth factor in the establishment and progression of bladder cancer and suggest that proepithelin may prove a novel biomarker for the diagnosis and prognosis of bladder neoplasms.
Description
Citation
Francesca Lovat, Alessandro Bitto, Shi-Qiong Xu, Matteo Fassan, Silvia Goldoni, David Metalli, Vera Wubah, Peter McCue, Ginette Serrero, Leonard G. Gomella, Raffaele Baffa, Renato V. Iozzo, Andrea Morrione, Proepithelin is an autocrine growth factor for bladder cancer, Carcinogenesis, Volume 30, Issue 5, May 2009, Pages 861–868, https://doi.org/10.1093/carcin/bgp050
Citation to related work
Oxford University Press
Has part
Carcinogenesis, Vol. 30, No. 5
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu